The Claim
Activation of adenosine A1 receptors in human neuroblastoma SH-SY5Y cells induces phosphorylation and cytoskeletal translocation of tau protein through ERK1/2 signaling.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human nerve cancer cells, activating adenosine A1 receptors causes tau protein to change its chemical state and move within the cell structure via the ERK1/2 signaling pathway.
See the scientific wording
Activation of adenosine A1 receptors in human neuroblastoma SH-SY5Y cells induces phosphorylation and cytoskeletal translocation of tau protein via ERK1/2 signaling, suggesting a potential molecular pathway linking A1 receptor activity to tau pathology in Alzheimer's disease.
When a specific receptor on nerve cells is activated, it turns on a chain of signals that ultimately modifies a brain protein, causing it to detach from its normal location and stick to the cell's internal skeleton, a change seen in Alzheimer's disease.
What the research says
1 studyIn lab-grown human nerve cells, turning on a specific receptor (A1) caused a brain protein called tau to change shape and move to the cell’s skeleton — exactly what happens in Alzheimer’s disease. This suggests that this receptor might play a role in making Alzheimer’s worse.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.